Cargando…
Decoding non-random mutational signatures at Cas9 targeted sites
The mutation patterns at Cas9 targeted sites contain unique information regarding the nuclease activity and repair mechanisms in mammalian cells. However, analytical framework for extracting such information are lacking. Here, we present a novel computational platform called Rational InDel Meta-Anal...
Autores principales: | Taheri-Ghahfarokhi, Amir, Taylor, Benjamin J M, Nitsch, Roberto, Lundin, Anders, Cavallo, Anna-Lina, Madeyski-Bengtson, Katja, Karlsson, Fredrik, Clausen, Maryam, Hicks, Ryan, Mayr, Lorenz M, Bohlooly-Y, Mohammad, Maresca, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144780/ https://www.ncbi.nlm.nih.gov/pubmed/30032200 http://dx.doi.org/10.1093/nar/gky653 |
Ejemplares similares
-
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
por: Bjursell, Mikael, et al.
Publicado: (2018) -
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
por: Carreras, Alba, et al.
Publicado: (2019) -
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery
por: Lundin, Anders, et al.
Publicado: (2020) -
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo
por: Bestas, Burcu, et al.
Publicado: (2023) -
Decoding Partner Specificity of Opioid Receptor Family
por: Barreto, Carlos A. V., et al.
Publicado: (2021)